Patient research
Evidence-Based
Biotech Equity Research.
Specialized in the biotech small- and mid-cap sector for institutional investors and family offices. Focus on risk discipline and thorough due diligence.
Judgement on uncertainty
Patient Research specializes in evidence-based buy-side equity research in the biotech sector. The focus is on analyzing small- and mid-cap companies for sophisticated family offices and institutional funds, combining deep scientific expertise with strict risk discipline.
Expertise
Small-cap analysis
Fundamental equity research for undervalued biotech stocks, with a focus on evidence-based valuation in the small- and mid-cap sector.
Due Diligence
Scientifically grounded evaluation of clinical data and study results, with strict adherence to confidentiality and discretion.
Risk discipline
Market dynamics analysis with a focus on long-term capital preservation and risk minimization for family offices and institutional funds.
You’re very welcome to reach out at contact@patient-research.com with any questions, ideas, or requests. Whether you’re seeking thoughtful analysis, exploring a potential collaboration, or simply wish to start a conversation, feel free to connect!
As an alternative, you can also reach out via the contact form below.